Volume 9, Issue 4

Search all Infectious Diseases and Therapy articles

December 2020

29 articles in this issue

Steroids and COVID-19: We Need a Precision Approach, Not One Size Fits All
Grant W. Waterer
Jordi Rello
Editorial Open access 16 September 2020 Pages: 701 - 705
Interleukin-6 Blocking vs. JAK-STAT Inhibition for Prevention of Lung Injury in Patients with COVID-19
Joseph Meletiadis
Sotirios Tsiodras
Panagiotis Tsirigotis
Commentary Open access 12 August 2020 Pages: 707 - 713
Early Treatment of COVID-19 Disease: A Missed Opportunity
Jamie I. Forrest
Craig R. Rayner
Edward J. Mills
Commentary Open access 13 October 2020 Pages: 715 - 720
Correction to: Early Treatment of COVID-19 Disease: A Missed Opportunity
Jamie I. Forrest
Craig R. Rayner
Edward J. Mills
Correction Open access 09 November 2020 Pages: 721 - 721
Epidemiology, Nasopharyngeal Carriage, Serotype Prevalence, and Antibiotic Resistance of Streptococcus pneumoniae in Indonesia
Cissy B. Kartasasmita
Sri Rezeki Hadinegoro
Amgad Gamil
Review Open access 30 August 2020 Pages: 723 - 736
Emerging Viral and Bacterial Infections: Within an Era of Opioid Epidemic
Jessica F. Jones
Jamie Legaspi
Jennifer Le
Review Open access 11 September 2020 Pages: 737 - 755
Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections
Tanaya Bhowmick
Melvin P. Weinstein
Review Open access 05 October 2020 Pages: 757 - 767
Part of 2 collections:

The Place of Meropenem-Vaborbactam in the Management of Carbapenem-Resistant Gram Negative Infections

The Place of Meropenem-Vaborbactam in the Management of Carbapenem-Resistant Gram-Negative Infections
An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam
Eric Wenzler
Patrick J. Scoble
Review Open access 06 October 2020 Pages: 769 - 784
Part of 2 collections:

The Place of Meropenem-Vaborbactam in the Management of Carbapenem-Resistant Gram-Negative Infections

The Place of Meropenem-Vaborbactam in the Management of Carbapenem-Resistant Gram-Negative Infections
Long-Term Persistence of Antibody Response with Two Doses of Inactivated Hepatitis A Vaccine in Children
Ashish Agrawal
Shafi Kolhapure
Monjori Mitra
Original Research Open access 24 July 2020 Pages: 785 - 796
Part of 1 collection:

Digital Features - Infectious Diseases
Combination of Percutaneous Lung Biopsy and Xpert MTB/RIF Ultra Enhances the Differential Diagnosis of Tuberculosis: A Prospective Cohort Study
Zhen Zhou
Chenghai Li
Hairong Huang
Original Research Open access 08 August 2020 Pages: 797 - 806
Genetic Risk Surveillance for Invasive Aspergillosis in Hematology Patients: A Prospective Observational Study
Tananun Tanpaibule
Natini Jinawath
Porpon Rotjanapan
Original Research Open access 28 August 2020 Pages: 807 - 821
Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study
Qiang Li
Weixia Li
Liang Chen
Original Research Open access 02 September 2020 Pages: 823 - 836
Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals
Georg M. N. Behrens
Anne Cossmann
Christine Happle
Original Research Open access 04 September 2020 Pages: 837 - 849
Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study
Masanori Atsukawa
Akihito Tsubota
KTK49 Liver Study Group
Original Research Open access 08 September 2020 Pages: 851 - 866
Effect of Bacillus clausii Capsules in Reducing Adverse Effects Associated with Helicobacter pylori Eradication Therapy: A Randomized, Double-Blind, Controlled Trial
Manuel Plomer
Marcos III Perez
Dorothea Maren Greifenberg
Original Research Open access 08 September 2020 Pages: 867 - 878
Correction to: Effect of Bacillus clausii Capsules in Reducing Adverse Effects Associated with Helicobacter pylori Eradication Therapy: A Randomized, Double-Blind, Controlled Trial
Manuel Plomer
Marcos III Perez
Dorothea Maren Greifenberg
Correction Open access 28 September 2020 Pages: 879 - 879
Seroprevalence and Determinants of Human Immunodeficiency Virus Infection Among Women of Reproductive Age in Mozambique: A Multilevel Analysis
Michael Ekholuenetale
Faith Owunari Benebo
Chimezie Igwegbe Nzoputam
Original Research Open access 10 September 2020 Pages: 881 - 900
Seroprevalence of Hepatitis B Virus Infection, Mother-To-Child Transmission, and Associated Risk Factors Among Delivering Mothers in Tigray Region, Northern Ethiopia: a Cross-Sectional Study
Kbrom Gemechu Kiros
Mekonnen Haftom Goyteom
Degena Bahrey Tadesse
Original Research Open access 15 September 2020 Pages: 901 - 911
Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial
Danyal Ibrahim
Latha Dulipsingh
Syed A. Hussain
Original Research Open access 20 September 2020 Pages: 913 - 926
In Vitro Antimicrobial Activity of Fosfomycin, Vancomycin and Daptomycin Alone, and in Combination, Against Linezolid-Resistant Enterococcus faecalis
Wei Yu
Jiajie Zhang
Yunqing Qiu
Original Research Open access 22 September 2020 Pages: 927 - 934
Faecal Microbiota Transplantation is Effective for the Initial Treatment of Clostridium difficile Infection: A Retrospective Clinical Review
Niloufar Roshan
Annabel K. Clancy
Thomas J. Borody
Original Research Open access 26 September 2020 Pages: 935 - 942
Effect of Corticosteroid Therapy on the Duration of SARS-CoV-2 Clearance in Patients with Mild COVID-19: A Retrospective Cohort Study
Cheng Ding
Xuewen Feng
Kaijin Xu
Original Research Open access 28 September 2020 Pages: 943 - 952
Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial
Thomas Lodise
Joe Yang
Marin Kollef
Original Research Open access 30 September 2020 Pages: 953 - 966
Lessons Learned from Long-Term Assessment of Rotavirus Vaccination in a High-Income Country: The Case of the Rotavirus Vaccine Belgium Impact Study (RotaBIS)
Baudouin Standaert
Danielle Strens
Marc Raes
Original Research Open access 06 October 2020 Pages: 967 - 980
Multidimensional Analysis of Risk Factors for the Severity and Mortality of Patients with COVID-19 and Diabetes
Juan Huang
Lin Zhu
Si Jin
Original Research Open access 28 October 2020 Pages: 981 - 1002
Etiology of Severe Community-Acquired Pneumonia in Adults Based on Metagenomic Next-Generation Sequencing: A Prospective Multicenter Study
Xiaodong Wu
Yuanyuan Li
Qiang Li
Original Research Open access 10 November 2020 Pages: 1003 - 1015
A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline
Nicholas Van Hise
Russell M. Petrak
Apoorv Kalra
Original Research Open access 15 October 2020 Pages: 1017 - 1028
Chest CT Features of 182 Patients with Mild Coronavirus Disease 2019 (COVID-19) Pneumonia: A Longitudinal, Retrospective and Descriptive Study
Huaping Liu
Shiyong Luo
Wei Wang
Original Research Open access 16 October 2020 Pages: 1029 - 1041
Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients
Adam G. Pizzuti
E. Yancy Murray
Bruce M. Jones
Brief Report Open access 21 October 2020 Pages: 1043 - 1053

Volume 9, Issue 4

Steroids and COVID-19: We Need a Precision Approach, Not One Size Fits All

Interleukin-6 Blocking vs. JAK-STAT Inhibition for Prevention of Lung Injury in Patients with COVID-19

Early Treatment of COVID-19 Disease: A Missed Opportunity

Correction to: Early Treatment of COVID-19 Disease: A Missed Opportunity

Epidemiology, Nasopharyngeal Carriage, Serotype Prevalence, and Antibiotic Resistance of Streptococcus pneumoniae in Indonesia

Emerging Viral and Bacterial Infections: Within an Era of Opioid Epidemic

Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections

An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam

Long-Term Persistence of Antibody Response with Two Doses of Inactivated Hepatitis A Vaccine in Children

Combination of Percutaneous Lung Biopsy and Xpert MTB/RIF Ultra Enhances the Differential Diagnosis of Tuberculosis: A Prospective Cohort Study

Genetic Risk Surveillance for Invasive Aspergillosis in Hematology Patients: A Prospective Observational Study

Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study

Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals

Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study

Effect of Bacillus clausii Capsules in Reducing Adverse Effects Associated with Helicobacter pylori Eradication Therapy: A Randomized, Double-Blind, Controlled Trial

Correction to: Effect of Bacillus clausii Capsules in Reducing Adverse Effects Associated with Helicobacter pylori Eradication Therapy: A Randomized, Double-Blind, Controlled Trial

Seroprevalence and Determinants of Human Immunodeficiency Virus Infection Among Women of Reproductive Age in Mozambique: A Multilevel Analysis

Seroprevalence of Hepatitis B Virus Infection, Mother-To-Child Transmission, and Associated Risk Factors Among Delivering Mothers in Tigray Region, Northern Ethiopia: a Cross-Sectional Study

Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial

In Vitro Antimicrobial Activity of Fosfomycin, Vancomycin and Daptomycin Alone, and in Combination, Against Linezolid-Resistant Enterococcus faecalis

Faecal Microbiota Transplantation is Effective for the Initial Treatment of Clostridium difficile Infection: A Retrospective Clinical Review

Effect of Corticosteroid Therapy on the Duration of SARS-CoV-2 Clearance in Patients with Mild COVID-19: A Retrospective Cohort Study

Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial

Lessons Learned from Long-Term Assessment of Rotavirus Vaccination in a High-Income Country: The Case of the Rotavirus Vaccine Belgium Impact Study (RotaBIS)

Multidimensional Analysis of Risk Factors for the Severity and Mortality of Patients with COVID-19 and Diabetes

Etiology of Severe Community-Acquired Pneumonia in Adults Based on Metagenomic Next-Generation Sequencing: A Prospective Multicenter Study

A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline

Chest CT Features of 182 Patients with Mild Coronavirus Disease 2019 (COVID-19) Pneumonia: A Longitudinal, Retrospective and Descriptive Study

Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients

Navigation